LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3958 | 4093 | 0.9672 | 0.9534 |
MCF7 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4182 | 4093 | 1.0218 | 1.0310 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3388 | 4093 | 0.8278 | 0.7555 |
MCF7 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 681 | 4093 | 0.1665 | -0.1831 |
MCF7 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3736 | 4093 | 0.9128 | 0.8762 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3813 | 4093 | 0.9316 | 0.9029 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4412 | 4093 | 1.0780 | 1.1107 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3621 | 4093 | 0.8847 | 0.8363 |
MCF7 | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3799 | 4093 | 0.9282 | 0.8980 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3206 | 4093 | 0.7833 | 0.6924 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1642 | 4093 | 0.4012 | 0.1500 |
MCF7 | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4004 | 4093 | 0.9783 | 0.9691 |
MCF7 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4044 | 4093 | 0.9882 | 0.9832 |
MCF7 | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3874 | 4093 | 0.9467 | 0.9243 |
MCF7 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4323 | 4093 | 1.0564 | 1.0800 |
MCF7 | R406 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3982 | 4093 | 0.9730 | 0.9616 |
MCF7 | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2135 | 4093 | 0.5218 | 0.3212 |
MCF7 | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4112 | 4093 | 1.0047 | 1.0067 |
MCF7 | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 1209 | 2534 | 4093 | 0.6193 | 0.4596 |
MCF7 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2242 | 4093 | 0.5478 | 0.3581 |
MCF7 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3973 | 4093 | 0.9707 | 0.9584 |
MCF7 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3764 | 4093 | 0.9197 | 0.8860 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2379 | 4093 | 0.5814 | 0.4058 |
MCF7 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1105 | 4093 | 0.2700 | -0.0363 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 2794 | 4093 | 0.6828 | 0.5497 |